Act Methylphenidate ER 36 mg (Methylphenidate Hydrochloride TABLET (EXTENDED-RELEASE)) 36 MG

ACT Methylphenidate ER 36 mg is an extended-release tablet designed for oral use. It contains methylphenidate hydrochloride, a central nervous system stimulant. This medication is commonly used to manage symptoms of ADHD and may help improve focus and concentration.

Strength

36 MG

Pack Size

100

Manufacturer / TM Owner

TEVA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ACT Methylphenidate ER 36 mg is primarily used to treat attention deficit hyperactivity disorder (ADHD). It works by affecting certain chemicals in the brain that may be unbalanced in people with ADHD. This can help improve focus, reduce impulsivity, and enhance concentration. The extended-release formulation is designed to provide a steady release of the medication over time, which can help maintain its effects throughout the day.

Side Effects

Common effects of ACT Methylphenidate ER 36 mg may include increased alertness, improved focus, and enhanced concentration. Some individuals may experience side effects such as decreased appetite, insomnia, or mild stomach upset. These effects can vary from person to person and may not be experienced by everyone who takes the medication.

Precautions & Warnings

ACT Methylphenidate ER 36 mg should be handled with care and stored properly to maintain its effectiveness. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be shared with others, even if they have similar symptoms. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

ACT Methylphenidate ER 36 mg may interact with other medications, including certain antidepressants, blood pressure medications, and other stimulants. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, consuming alcohol while taking this medication may increase the risk of side effects.

Frequently Asked Questions

ACT Methylphenidate ER 36 mg is used to treat attention deficit hyperactivity disorder (ADHD) by improving focus and concentration.

ACT Methylphenidate ER 36 mg should be taken orally, typically once daily in the morning. Follow the specific instructions provided by your healthcare provider.

Common side effects may include decreased appetite, insomnia, and mild stomach upset. These effects can vary from person to person.

It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

The safety of long-term use should be discussed with a healthcare provider, who can provide personalized advice based on your specific situation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.